You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

PROCHLORPERAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prochlorperazine, and what generic alternatives are available?

Prochlorperazine is a drug marketed by Alpharma Us Pharms, Baxter Hlthcare, Able, Cosette, Watson Labs, Morton Grove, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Teva Parenteral, Viwit Pharm, Wyeth Ayerst, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Mylan, Novitium Pharma, Teva Pharms, and Zydus. and is included in forty-three NDAs.

The generic ingredient in PROCHLORPERAZINE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine

A generic version of PROCHLORPERAZINE was approved as prochlorperazine maleate by NOVITIUM PHARMA on June 13th, 2022.

  Try a Trial

Drug patent expirations by year for PROCHLORPERAZINE
Drug Prices for PROCHLORPERAZINE

See drug prices for PROCHLORPERAZINE

Drug Sales Revenue Trends for PROCHLORPERAZINE

See drug sales revenues for PROCHLORPERAZINE

Recent Clinical Trials for PROCHLORPERAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of CalgaryPhase 3
Ehsan MalekEarly Phase 1
New York State Psychiatric InstitutePhase 2

See all PROCHLORPERAZINE clinical trials

Pharmacology for PROCHLORPERAZINE
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for PROCHLORPERAZINE

US Patents and Regulatory Information for PROCHLORPERAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duramed Pharms Barr PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 089484-001 Jan 20, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Morton Grove PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate SYRUP;ORAL 088597-001 Oct 25, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 040185-002 Oct 28, 1996 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.